Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
pH-dependent membrane interaction is a general term for the phenomenon where the binding or insertion of peptides, proteins, or other molecules into lipid membranes is regulated by the pH of the environment[1][2][3][4][7]. These interactions often rely on the protonation or deprotonation of certain amino acid side chains (such as histidine or glutamate), which alters the molecule's charge and affinity for the membrane. This property is being exploited in the design of peptides that selectively target or anchor to acidic environments such as tumors, inflamed tissue, or infected sites. Well-studied examples include engineered peptides like pHLIP and TYPE7, which insert into cell membranes at low pH and can be used for targeted drug delivery or modulation of membrane proteins[2][3]. The phenomenon is not a discrete target but rather a strategy that enables selectivity in hostile or abnormal microenvironments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on pH-dependent membrane interaction.